Cerebral Infarction Volume
The volume of brain tissue affected by ischemic stroke, used as a biomarker for stroke severity and neurological outcome.
TL;DR
Cerebral infarction (stroke) volume is a clinical imaging outcome — no over-the-counter supplement has proven ability to limit stroke size. Prevention through risk-factor control is the only evidence-based strategy.
Why It Matters
Infarct volume after ischemic stroke predicts disability and mortality. Research into neuroprotective agents (including citicoline in some trials) has largely failed to translate from animal models to human benefit. Time-to-reperfusion (thrombolysis, thrombectomy) determines tissue salvage. Supplements marketed for stroke recovery lack convincing human evidence and should never delay emergency care.
How to Measure
Stroke prevention monitoring: blood pressure, lipids, glucose, and pulse-rhythm checks. Infarct volume itself is measured only by MRI/CT in hospital.
Biomarkers
Optimization Protocol
No supplement protocol is evidence-based for limiting infarct volume. Prevention: blood pressure control (single biggest lever), statin therapy when indicated, anticoagulation for atrial fibrillation, smoking cessation. Act FAST on stroke symptoms — call emergency services immediately.
Lifestyle Levers
- •Blood pressure control
- •Smoking cessation
- •Anticoagulation adherence (if atrial fibrillation)
- •Diabetes management
- •Regular aerobic exercise
Supporting Supplements
Supporting Research
Frequently Asked Questions
Typical Timeframe
Not applicable — acute medical emergency outcome.
Research Summary
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.